“…Since compound 1 features an unprecedented C19 BIA skeleton, a biosynthetic pathway of 1 together with two coisolates was proposed (Scheme ). As mentioned above, the normal C 16 BIAs (such as armepavine) are synthesized by condensation of dopamine and 4-hydroxyphenylacetaldehyde, which could be both derived from l -tyrosine. , With the key involvement of berberine bridge enzyme, − C 16 BIAs could be transformed to C 17 BIAs, such as epiberberine and N -methylsinactine. , Stevens rearrangement of a tetrahydroprotoberberine N -methyl salt precursor ( N -methylsinactine) would produce C 17 spiro-BIA, − such as sibiricine. , The C 17 spiro-BIA derivative is attacked by asparagine and through dehydration and dehydrogenation could produce rare C 21 spiro-BIA, such as hyperectine . The sibiricine analogue may undergo enzymatic reduction and ring-opening reaction to produce a benzaldehyde derivative.…”